Navigation Links
Hidden Heart Risk Revealed: Non-Profit Empowers 30% Of Americans At Risk To Be Advocates
Date:11/16/2013

SAN FRANCISCO, Nov. 16, 2013 /PRNewswire/ -- Cardiovascular disease is the #1 killer of Americans, yet 50% of hospital admissions for coronary artery disease have normal LDL-cholesterol.(i) The Lipoprotein(a) Foundation is revealing this hidden risk for patients.

"Patients with elevated Lipoprotein(a) [Lp(a)] levels have an increased risk of cardiovascular disease, including heart attack, stroke and peripheral arterial disease(ii). Lp(a) is a genetically-determined condition that is not responsive to lifestyle changes. Elevated Lp(a) levels are present in about 30% of the population at large(iii). Since Lp(a) is not currently routinely measured by physicians, many patients are unaware that they have elevated levels. Lp(a) can be measured with a routine lipid blood panel, but there is no adequate treatment currently to lower levels. Knowledge of elevated Lp(a) levels may motivate physicians to treat their patients' risk factors more aggressively and patients to live a heart healthy lifestyle until specific therapies can be developed and tested clinically," said Sotirios Tsimikas, M.D., Professor of Medicine and Director of Vascular Medicine at the University of California San Diego. "The Lipoprotein(a) Foundation is a needed resource for education of patients and their families that aims to raise public awareness of the potential risk of elevated Lp(a) levels that will hopefully lead to prevention and early treatment of cardiovascular disease."

"It is now documented that elevated Lp(a) levels not only cause heart attacks, but also aortic valve stenosis, another serious and potentially deadly heart disease. Therefore like those with heart attacks, individuals with aortic valve stenosis and their family members should have Lp(a) measured," said Professor, Chief Physician Børge Nordestgaard from Copenhagen University Hospital in Denmark. He adds "It is a great commitment to initiate the Lipoprotein(a) Foundation, as this may help more individuals and patients being diagnosed with this genetic disorder."(iv)

See Sandra's story here: http://youtu.be/1D3ahEbiLr4. Find out more about the mission of the Lipoprotein(a) Foundation and people can receive the latest information on Lp(a) by becoming members of the Lipoprotein(a) Foundation at www.lipoproteinafoundation.org.

Media Contact:
Sandra Tremulis
President and Founder 
serevill@aol.com
(650) 995-3242
http://www.lipoproteinafoundation.org

i Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines. AM Heart J 2009;157:111-7.e2.
http://www.ncbi.nlm.nih.gov/pubmed/19081406

ii Nordestgaard B, Chapman J, et al. Lipoprotein(a) as a cardiovascular risk factor current status. European Heart J 2010;31, 2844-2853
http://www.ncbi.nlm.nih.gov/pubmed/20965889

iii Tsimikas S, Hall J. Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease. J Am Coll Cardiol. 2012 Aug 21;60(8):716-21. doi: 10.1016/j.jacc.2012.04.038
http://www.ncbi.nlm.nih.gov/pubmed/22898069

iv Thanassoulis G, et al. Genetic associations with valvular calcification and aortic stenosis.N Engl J Med. 2013 Feb 7;368(6):503-12. doi: 10.1056/NEJMoa1109034
http://www.ncbi.nlm.nih.gov/pubmed/23388002


'/>"/>
SOURCE The Lipoprotein(a) Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Hidden Complications of Single-Sided Deafness
2. Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans
3. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
4. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
5. 1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
6. HeartWare Presentation At The Canaccord Genuity Medical Technology & Diagnostics Forum To Be Webcast
7. Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
8. Millennium HealthCare Launches its Nation Wide Roll Out with Heart Smart Inc.
9. HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012
10. Preventing Heart Disease One Step at a Time
11. Study Finds Pre-Hospital Administration Of Bivalirudin Substantially Improves Outcomes Compared To Heparin In Heart Attack Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... February 28, 2017 The global  pulse oximeters market  is ... by Grand View Research, Inc. The pulse oximeters market is anticipated to witness ... prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, ... ... Grand View Research Logo ...
(Date:2/28/2017)... Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth ... the company,s senior management team will take place today at 8:30 ... ... very successful year for Nordic Nanovector. We achieved important milestones with ... candidates and build the foundation of R&D innovation and expertise for ...
(Date:2/27/2017)... Ga., Feb. 27, 2017 Halyard Health, Inc. (NYSE: ... 2016 results and provided its 2017 outlook and related key ... sales were $410 million, a 2 percent increase compared to ... fourth quarter 2016 was $10 million compared to net income ... quarter adjusted net income was $24 million compared to adjusted ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre (SCHC), ... Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a ... the Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC ... North America, today announced it would be offering some it’s exclusive product line ... on crafting quality and unique baby clothing/feeding products, will team up with AMAZON ...
Breaking Medicine News(10 mins):